ᱢᱚᱰᱟᱨᱱᱟ ᱠᱳᱵᱷᱤᱰ-᱑᱙ ᱴᱤᱠᱟᱹ

ᱢᱚᱰᱟᱨᱱᱟ ᱠᱳᱵᱷᱤᱰ-᱑᱙ ᱴᱤᱠᱟᱹ
INN: elasomeran
	Vials of the Moderna COVID-19 vaccine
ᱴᱤᱠᱟᱹ ᱨᱮᱭᱟᱜ ᱵᱚᱨᱱᱚᱱ
ᱡᱚᱥ ᱟᱡᱟᱨ	SARS-CoV-2
ᱞᱮᱠᱟᱱ	mrna
ᱠᱞᱤᱱᱤᱠᱟᱞ ᱰᱮᱴᱟ
ᱨᱟᱹᱲ	/məˈdɜːrnə/ mə-DUR-nə
ᱵᱮᱯᱟᱨ ᱧᱩᱛᱩᱢᱠᱚ	Spikevax
ᱮᱴᱟᱜ ᱧᱩᱛᱩᱢ	mRNA-1273, CX-024414, COVID-19 mRNA Vaccine Moderna, TAK-919, Moderna COVID‑19 Vaccine, COVID‑19 Vaccine Moderna, COVID-19 Vaccine Moderna Intramuscular Injection
ᱮ.ᱮᱭᱤᱪ.ᱮᱯᱷ.ᱮᱥ/ᱰᱨᱟᱜᱥ.ᱠᱚᱢ	Multum Consumer Information
ᱢᱮᱰᱞᱟᱭᱤᱱᱯᱞᱟᱥ	a621002
ᱰᱮᱴᱟ	US DailyMed: Moderna_COVID-19_Vaccine;
ᱵᱮᱵᱷᱟᱨ ᱨᱮᱱᱟᱜ; ᱴᱷᱟᱶ	Intramuscular
ᱮ.ᱴᱤ.ᱥᱤ ᱠᱳᱰ	None;
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ
ᱟᱹᱱᱟᱹᱨᱤ ᱦᱟᱞᱚᱛ	CA: Schedule D; Authorized by interim order ; UK: Marketing authorization granted ; US: Standing Order; Unapproved (Emergency Use Authorization); EU: Conditional marketing authorization granted ; Full list : List of Moderna COVID-19 vaccine authorizations;
ᱩᱯᱨᱩᱢᱤᱭᱟᱹ
ᱥᱤ.ᱮ.ᱮᱥ ᱱᱚᱢᱵᱚᱨ	2430046-03-8 ;
ᱰᱨᱟᱜᱵᱮᱸᱠ	DB15654;
ᱭᱩ.ᱮᱱ.ᱟᱭ.ᱟᱭ	EPK39PL4R4;
ᱠᱮ.ᱤ.ᱡᱤ.ᱡᱤ	D12114;

ᱢᱚᱰᱟᱨᱱᱟ ᱠᱳᱵᱷᱤᱰ-᱑᱙ ᱴᱤᱠᱟᱹ ᱡᱟᱸᱦᱟᱸ ᱫᱚ ᱪᱤᱱᱦᱟᱹ ᱧᱩᱛᱩᱢ ᱮᱢ.ᱟᱨ.ᱮᱱ.ᱮ ᱞᱮᱠᱟᱛᱮ ᱦᱚᱸ ᱠᱚ ᱵᱟᱰᱟᱭ ᱜᱮᱭᱟ᱾ ᱱᱮᱥᱱᱟᱞ ᱤᱱᱥᱴᱤᱴᱤᱴᱣᱴ ᱚᱵᱽ ᱮᱞᱟᱨᱡᱤ ᱮᱱᱰ ᱤᱯᱷᱮᱠᱴᱤᱭᱟᱥ ᱰᱤᱡᱤᱡᱮᱥ (ᱮᱱ.ᱟᱭ.ᱮ.ᱟᱭ.ᱰᱤ), ᱵᱟᱭᱳᱢᱮᱰᱤᱠᱮᱞ ᱮᱰᱵᱷᱟᱱᱥᱰ ᱨᱤᱥᱟᱨᱪ ᱮᱱᱰ ᱰᱮᱵᱷᱮᱞᱚᱯᱢᱮᱱᱴ ᱚᱛᱷᱚᱨᱤᱴᱤ (ᱵᱤ.ᱮ.ᱟᱨ.ᱰᱤ.ᱮ) ᱟᱨ ᱢᱚᱨᱰᱟᱱᱟ ᱟᱜ ᱵᱮᱱᱟᱣᱟᱱ ᱢᱤᱫᱴᱮᱱ ᱠᱳᱵᱷᱤᱰ-᱑᱙ ᱴᱤᱠᱟᱹ ᱠᱟᱱᱟ᱾ ᱱᱚᱣᱟ ᱴᱤᱠᱟᱹ ᱨᱮᱱᱟᱜ ᱫᱚ ᱵᱟᱨᱮᱭᱟ ᱰᱳᱡᱽ ᱦᱟᱛᱟᱣ ᱞᱟᱜᱟᱜᱼᱟ᱾ ᱯᱟᱹᱦᱤᱞ ᱫᱷᱟᱣ ᱦᱟᱛᱟᱣ ᱯᱩᱱ ᱦᱟᱯᱛᱟ ᱛᱟᱭᱚᱢ ᱨᱮᱜᱮ ᱫᱚᱥᱟᱨ ᱰᱳᱡᱽ ᱫᱚ ᱦᱟᱛᱟᱣ ᱦᱩᱭᱩᱜᱼᱟ᱾ ᱱᱤᱭᱟᱹ ᱴᱤᱠᱟᱹ ᱨᱮᱱᱟᱜ ᱰᱳᱡᱽ ᱫᱚ ᱐.᱕ ᱢᱤᱞᱤ ᱦᱩᱭᱩᱜᱼᱟ᱾

ᱮᱢᱟᱨᱮᱱ-᱑᱒᱗᱓ ᱨᱮᱱᱟᱜ ᱵᱮᱵᱷᱟᱨ ᱫᱚ ᱒᱐᱒᱐ ᱥᱮᱨᱢᱟ ᱨᱮᱱᱟᱜ ᱑᱘ ᱰᱤᱥᱮᱢᱵᱚᱨ ᱢᱟᱨᱠᱤᱱ ᱡᱩᱠᱛᱳᱨᱟᱥᱴᱨᱚ ᱟᱜ ᱨᱟᱱ ᱟᱨ ᱡᱚᱢ ᱵᱤᱵᱷᱟᱜᱽ ᱮ ᱜᱷᱳᱥᱳᱱᱟ ᱞᱮᱫᱟ᱾ ᱱᱚᱣᱟ ᱴᱤᱠᱟᱹ ᱫᱚ ᱠᱟᱱᱟᱰᱟ ᱨᱮ ᱒᱐᱒᱐ ᱥᱮᱨᱢᱟ ᱨᱮᱱᱟᱜ ᱒᱓ ᱰᱤᱥᱮᱢᱵᱚᱨ, ᱤᱣᱨᱳᱯᱤᱭᱳ ᱤᱣᱱᱤᱭᱚᱱ ᱨᱮ ᱒᱐᱒᱑ ᱥᱮᱨᱢᱟ ᱨᱮᱱᱟᱜ ᱖ ᱡᱟᱱᱩᱣᱟᱨᱤ ᱟᱨ ᱘ ᱡᱟᱱᱩᱣᱟᱨᱤ ᱫᱚ ᱡᱩᱠᱛᱚ ᱨᱟᱡᱡᱚ ᱨᱮ ᱵᱮᱵᱷᱟᱨ ᱨᱮᱱᱟᱜ ᱟᱹᱭᱫᱟᱹᱨᱤᱭ ᱧᱟᱢ ᱟᱠᱟᱫᱟ᱾

ᱠᱮᱢᱤᱥᱴᱨᱤ[ᱥᱟᱯᱲᱟᱣ | ᱯᱷᱮᱰᱟᱛ ᱥᱟᱯᱲᱟᱣ]

ᱛᱮᱭᱟᱨ[ᱥᱟᱯᱲᱟᱣ | ᱯᱷᱮᱰᱟᱛ ᱥᱟᱯᱲᱟᱣ]

ᱱᱟᱜᱟᱢ[ᱥᱟᱯᱲᱟᱣ | ᱯᱷᱮᱰᱟᱛ ᱥᱟᱯᱲᱟᱣ]

ᱵᱟᱨᱦᱮ ᱡᱚᱱᱚᱲ[ᱥᱟᱯᱲᱟᱣ | ᱯᱷᱮᱰᱟᱛ ᱥᱟᱯᱲᱟᱣ]

ᱥᱟᱹᱠᱷᱹᱭᱟᱹᱛ[ᱥᱟᱯᱲᱟᱣ | ᱯᱷᱮᱰᱟᱛ ᱥᱟᱯᱲᱟᱣ]

↑ "Takeda Announces Approval of Moderna's COVID-19 Vaccine in Japan" (Press release). Takeda. 21 May 2021.
↑ Moderna (23 October 2019). mRNA-3704 and Methylmalonic Acidemia (Video). YouTube. Retrieved 19 January 2021.
↑ "Regulatory Decision Summary – Moderna COVID-19 Vaccine". Health Canada. 23 December 2020. Retrieved 23 December 2020.
↑ "Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2)". COVID-19 vaccines and treatments portal. 23 December 2020. Retrieved 23 December 2020.
↑ "Spikevax (previously COVID-19 Vaccine Moderna) EPAR". European Medicines Agency (EMA). 4 January 2021. Retrieved 29 June 2021.
↑ "Information for Healthcare Professionals on COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 8 January 2021.
↑ "Conditions of Authorisation for COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 9 January 2021.
↑ "Regulatory approval of COVID-19 Vaccine Moderna". gov.uk. 1 April 2021.
↑ "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Press release). Retrieved 18 December 2020.
↑ "Moderna COVID-19 Vaccine – cx-024414 injection, suspension". DailyMed. Retrieved 20 December 2020.
↑ Moderna COVID-19 Vaccine Emergency Use Authorization. U.S. Food and Drug Administration (FDA) (Report). 12 August 2021. Archived from the original (PDF) on 14 August 2021. Retrieved 13 August 2021. This article incorporates text from this source, which is in the public domain.
↑ "Moderna COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older" (PDF). Centers for Disease Control and Prevention (CDC). 16 July 2021. Archived from the original (PDF) on 14 August 2021.

[TakRNA-1] "Takeda Announces Approval of Moderna's COVID-19 Vaccine in Japan" (Press release). Takeda. 21 May 2021.

[2] Moderna (23 October 2019). mRNA-3704 and Methylmalonic Acidemia (Video). YouTube. Retrieved 19 January 2021.

[CA_Moderna_decision-3] "Regulatory Decision Summary – Moderna COVID-19 Vaccine". Health Canada. 23 December 2020. Retrieved 23 December 2020.

[CA_Moderna_product_description-4] "Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2)". COVID-19 vaccines and treatments portal. 23 December 2020. Retrieved 23 December 2020.

[Spikevax_EPAR-5] "Spikevax (previously COVID-19 Vaccine Moderna) EPAR". European Medicines Agency (EMA). 4 January 2021. Retrieved 29 June 2021.

[gov.uk-6] "Information for Healthcare Professionals on COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 8 January 2021.

[Conditions_of_Authorisation_for_COV-7] "Conditions of Authorisation for COVID-19 Vaccine Moderna". Medicines and Healthcare products Regulatory Agency (MHRA). 8 January 2021. Retrieved 9 January 2021.

[UKapproval-8] "Regulatory approval of COVID-19 Vaccine Moderna". gov.uk. 1 April 2021.

[FDA_PR_20201218-9] "FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Press release). Retrieved 18 December 2020.

[Moderna_COVID-19_Vaccine_FDA_label-10] "Moderna COVID-19 Vaccine – cx-024414 injection, suspension". DailyMed. Retrieved 20 December 2020.

[Moderna_COVID-19_Vaccine_FDA_EUA-11] Moderna COVID-19 Vaccine Emergency Use Authorization. U.S. Food and Drug Administration (FDA) (Report). 12 August 2021. Archived from the original (PDF) on 14 August 2021. Retrieved 13 August 2021. This article incorporates text from this source, which is in the public domain.

[CDC_standing_order-12] "Moderna COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older" (PDF). Centers for Disease Control and Prevention (CDC). 16 July 2021. Archived from the original (PDF) on 14 August 2021.

[᱒]

[᱑]

[᱓]

[᱔]

[᱖]

[᱗]

[᱘]

[᱙]

[᱑᱐]

[᱑᱑]

[᱑᱒]

[᱕]